Summary

● In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.

● The company has poor fundamentals for a short-term investment strategy.


Strengths

● According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.

● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

● The stock is in a well-established, long-term rising trend above the technical support level at 29.05 CNY


Weaknesses

● The company does not generate enough profits, which is an alarming weak point.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 69.89 times its estimated earnings per share for the ongoing year.

● The company is not the most generous with respect to shareholders' compensation.

● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.